Home>
US Stocks>
Verve Therapeutics Inc

Verve Therapeutics Inc share price today

(VERV)

Verve Therapeutics Inc share price is $6.47 & ₹547.94 as on 7 Dec 2024, 2.30 'hrs' IST

$6.47

▲

0.36

(5.89%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Verve Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Verve Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Verve Therapeutics Inc. Get details on the Indian mutual funds that are investing in Verve Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Verve Therapeutics Inc's financials.

Verve Therapeutics Inc share price movements

$6.08
$6.68
$6.47
6.03%
Downside
Day's Volatility :8.98%
Upside
3.14%
$4.31
$19.34
$6.47
33.46%
Downside
52 Weeks Volatility :77.74%
Upside
66.55%

Verve Therapeutics Inc Returns

Period	Verve Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	8.72%	-5.7%	0.0%
6 Months	13.99%	-0.9%	0.0%
1 Year	-52.23%	10.0%	0.0%
3 Years	-83.02%	9.3%	-21.5%

Verve Therapeutics Inc Key Statistics

in dollars & INR

Previous Close	$6.11
Open	$6.2
Today's High	$6.68
Today's Low	$6.08
Market Capitalization	$561.3M
Today's Volume	$1.4M
52 Week High	$19.34
52 Week Low	$4.305
Revenue TTM	$24.4M
EBITDA	$-220.0M
Earnings Per Share (EPS)	$-2.33
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-40.67%

How to invest in Verve Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Verve Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Verve Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Verve Therapeutics Inc or VERV on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Verve Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Verve Therapeutics Inc shares which would translate to 0.131 fractional shares of Verve Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Verve Therapeutics Inc

57%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Verve Therapeutics Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 57% more investors are searching Verve Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Verve Therapeutics Inc

Alphabet Inc
14.59%
BlackRock Inc
7.82%
Millennium Management LLC
5.86%
State Street Corp
5.02%
Vanguard Group Inc
4.73%
Casdin Capital, LLC
4.72%

Analyst Recommendation on Verve Therapeutics Inc

Buy

82%Buy

17%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Verve Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Verve Therapeutics Inc

What analysts predicted

Upside of 304.98%

Current:

$6.47

Target:

$26.20

Insights on Verve Therapeutics Inc

Increasing Revenue
Revenue is up for the last 9 quarters, 929.0K → 6.86M (in $), with an average increase of 21.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 5 quarters, -45.75M → -50.13M (in $), with an average decrease of 2.3% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 42.1% return, outperforming this stock by 94.8%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.7% return, outperforming this stock by 122.6%

Verve Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Verve Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Verve Therapeutics Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Verve Therapeutics Inc	-3.93%	13.99%	-52.23%	-83.02%	-86.72%
Regeneron Pharmaceuticals, Inc.	-6.86%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	10.16%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.5%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-8.46%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Verve Therapeutics Inc	2.34	NA	NA	-2.45	-0.41	-0.22	NA	6.01
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Verve Therapeutics Inc	Buy	$561.3M	-86.72%	2.34	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Verve Therapeutics Inc

verve therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. the company brings together human genetics analysis and gene editing – two of the biggest breakthroughs in 21st century biomedicine – to develop transformative therapies for coronary heart disease. verve is developing medicines, administered once in life, to safely edit the genome of adults to permanently lower ldl cholesterol and triglyceride levels and thereby treat coronary heart disease. founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, verve is backed by a top-tier syndicate of investors, including gv (formerly google ventures), arch venture partners, f-prime capital, biomatics capital, wellington management, casdin capital, and partners innovation fund. the company was recognized as a "2020 best places to work" by the boston business journal. verve is headquartered in cambridge, massachusetts.

Organization	Verve Therapeutics Inc
Employees	255
CEO	Dr. Sekar Kathiresan M.D.
Industry	Services

Management People of Verve Therapeutics Inc

Name	Title
Dr. Sekar Kathiresan M.D.	Co-Founder, CEO & Director
Ms. Allison Dorval CPA	CFO & Principal Accounting Officer
Mr. Andrew D. Ashe J.D.	President, COO & General Counsel
Dr. Kiran Musunuru M.D., M.P.H., Ph.D.	Co-Founder
Dr. J. Keith Joung M.D., Ph.D.	Co-Founder
Dr. Anthony Philippakis M.D., Ph.D.	Co-Founder & Scientific Advisory Board Member
Dr. Barry S. Ticho FACC, M.D., Ph.D.	Co-Founder
Mr. Issi Rozen M.B.A.	Co-Founder & Strategic Advisor
Dr. Troy Lister Ph.D.	Chief Scientific Officer
Ms. Joan Nickerson M.B.A.	Chief Administrative Officer

Important FAQs about investing in Verve Therapeutics Inc from India :

What is Verve Therapeutics Inc share price today?

Verve Therapeutics Inc (VERV) share price today is $6.47.

Can Indians buy Verve Therapeutics Inc shares?

Yes, Indians can invest in the Verve Therapeutics Inc (VERV) from India.

With INDmoney, you can buy Verve Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Verve Therapeutics Inc at zero transaction cost.

How can I buy Verve Therapeutics Inc shares from India?

It is very easy to buy Verve Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Verve Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Verve Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Verve Therapeutics Inc stocks?

To start investing in Verve Therapeutics Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.